REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Maxpharma Baltija (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Maxpharma Baltija Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Maxpharma Baltija is based in Lithuania, with the head office in Vilnius. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on August 12, 2003. The total number of employees is currently 10 (2025). The latest financial highlights indicate a net sales revenue increase of 18.28% in 2024. The enterprise’s net profit margin increased by 8.81% in 2024.

Headquarters
Saltoniskiu g. 29
Vilnius; Vilnius county; Postal Code: LT-08106

Contact Details: Purchase the UAB Maxpharma Baltija report to view the information.

Basic Information
Total Employees:
Purchase the UAB Maxpharma Baltija report to view the information.
Registered Capital:
Purchase the UAB Maxpharma Baltija report to view the information.
Financial Auditors:
Purchase the UAB Maxpharma Baltija report to view the information.
Incorporation Date:
August 12, 2003
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after UAB Maxpharma Baltija report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.28%
Total Operating Revenue
18.28%
Net Profit/Loss for the Period
65.27%
Total Equity
20.97%
Net Profit Margin
8.81%
Return on Equity (ROE)
5.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?